Filing Details

Accession Number:
0001038133-16-000303
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-10 15:18:41
Reporting Period:
2016-08-09
Filing Date:
2016-08-10
Accepted Time:
2016-08-10 15:18:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1038133 Heska Corp HSKA Biological Products, (No Disgnostic Substances) (2836) 770192527
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1570456 Steve Asakowicz 3760 Rocky Mountain Avenue
Loveland CO 80538
Evp, Comp. Animal Health Sales No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-08-09 4,698 $8.35 12,858 No 4 M Direct
Common Stock Disposition 2016-08-09 4,698 $52.55 8,160 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2016-08-09 4,698 $0.00 4,698 $8.35
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
802 2013-08-24 2023-02-23 No 4 M Direct
Footnotes
  1. One-eighth of the shares will become vested and exercisable on August 24, 2013, the remaining shares will become vested and exercisable in equal monthly installments through February 24, 2017.